KESHO

TOPIC: Colon Cancer; A Multidisciplinary Approach
2019-05-23 20:00 - 22:00 (Africa/Nairobi) | Radisson Blu, Upperhill Nairobi, Nairobi, Nairobi, 00100, Kenya
This was a busy month for our members with three educational events! Dr. Joe Ruturi Cardiothoracic Surgeon and Dr. Solomon Mutua Clinical Oncologist started off the month with discussions on upper GI cancers, in particular esophageal cancer. KESHO collaborated with ROCHE in their sub-Saharan MPANGO two-day meeting in which many of our members were speakers. The conference focused on triple negative and HER2 breast cancer, colon and lung cancer. The month ended with an excellent multidisciplinary meeting on colon cancer spearheaded by our very own past Chair, Dr. Gladwell Kiarie Medical Oncologist and Dr. Rajendra Chauhan Surgical Oncologist. There was a lot of input from our surgical and radiation colleagues.

TOPIC: HIV Malignancies Symposium
2019-04-27 20:00 - 22:00 | Movenpick Hotel, Nairobi
KESHO held a half-day joint symposium with the HIV Clinicians Society discussing the various aspects of HIV related malignancies and how we can better co-manage these patients for improved outcomes. More local research is needed to understand the true prevalence of a co-diagnosis of HIV and cancer and in particular non-AIDS defining malignancies.

Topic: Acute Leukaemia
2019-03-28 00:00 - 23:59 | Sarova Panafric Hotel, Nairobi, Kenya., Kenya
Prof. Nicholas Abinya Medical Oncologist and Dr. Anne Mwirigi Haematologist gave stimulating perspectives on their care of patients with AML in a public versus a private setting. This led to discussions on collaborations on improving standards of care in our country and in particular with regards to supportive care and financing. KESHO is now engaging with NHIF and the NCCP to outline a treatment package for these patients that factor other costs apart from direct chemotherapy drugs.

Topic: Updates on Recently Launched Cancer Screening Guidelines
2019-02-28 00:00 - 23:59
In line with the launch of the Kenya Cancer Screening guidelines, Dr Andrew Odhiambo Medical Oncologist and Dr Primus Ochieng Clinical Oncologist presented on their perspectives on the new guidelines and their experience in other settings outside of Kenya. The Screening Guidelines is as shown below:

Loading Viewer...

Topic: Updates in Breast Cancer Management
2019-01-31 00:00 - 23:59 | Sarova Panafric Hotel, Nairobi, Kenya., Kenya
We started off the year discussing the most common cancer in women in Kenya and worldwide with two presentations. Dr Miriam Mutebi Surgical Oncologist gave an update on the surgical techniques of breast cancer management and Dr Njoki Njiriani Clinical Oncologist talking on new therapies for advanced hormone positive breast cancer

The 5th Kenya International Cancer Conference
2018-11-15 00:00 - 2018-11-17 23:59 | Crowne Plaza, Nairobi, Kenya., Kenya
Theme: Integrating Research and Practice

The latest cancer statistics show that the cancer burden is expected to rise to 18.1million new cases and 9.6million cancer deaths in 2018 globally. Kenya has less than 30 cancer specialists mostly in the urban settings against an increasing cancer population currently documented at 43,000 patients across the country illuminating a dire professional deficit and much needed concerted effort by all players to curb the catastrophic effects of cancer burden.
Cancer control research therefore seeks to identify and evaluate means of reducing cancer morbidity and mortality and thereby improving the quality of life of people living with, recovering from or dying of cancer. Knowledge of the facts and statistics, plausible risk factors of disease and emergent complexes, suitable interventions in response as well as the policies and frameworks that help facilitate cancer control is essential in reducing incidents, rates and mortality due to cancer. Through research, cancer experts are able to tackle cancer with community and country/region specific interventions.
The 5th International Cancer Conference in 2018 by KESHO hosted in partnership with the Ministry of Health, Kenya, brought together an average of more than 250 participants each conference day. They comprised both delegates and partners whose profile ranged from oncologists, radiologists, pharmacists, medical officers and a myriad of players in cancer management and treatment including health authorities and experts from the state, non-governmental organizations and projects working in screening and surveillance of risk and crisis management as well as scientists, advocacy groups and individuals/persons living with cancer to discuss integrating cancer treatment practice and research. More than30% of the participants, were doctors with the rest being diverse practitioners mitigating cancer related complexes. It was an opportunity to review and evaluate performance and discuss various advances made so far in cancer treatment and management both locally and globally and how to embrace them as well as create a platform to decentralize cancer information from few experts to devolved layers in cancer management such as general physicians and caregivers at county level. The program included diverse content from renowned experts in several related fields and a well versed keynote speaker from around the world and local clinical specialists and practitioners in research, policy makers and cancer advocates to infuse a more holistic perspective.
The conference format included plenary sessions, context specific breakout sessions, illustrative exhibitions by sector players, workshops including research workshop facilitated by international and local researchers who steer participants in navigating the enormous dilemma in conducting research (quantitative and qualitative), grant writing and getting published and the first ever KESHO-ASCO Joint Symposium showcasing KESHO members and ASCO faculty tackling cases in the setting of precision medicine and immunotherapy. Additionally, there were social activities linked and tilted to the conference activities and themes such as a Gala Dinner by Texas Cancer Centre in Kenya enriched by a fashion show with cancer survivor runway models and a Cancer awareness concert by renowned celebrity artists.
The theme of the conference in 2018 was ‘Integrating Research and Practice’ with the main objective being to highlight the research work centred on cancer treatment and management and create a platform for local, regional and international health care providers to present their work, hear from each other, learn and encourage collaboration. The following were the exhibitors who participated in this conference:

Lancet
Bayer
Metropolis
Salama Pharmaceuticals
SANOFI
SUN Pharma

MERCK
ORIGENS Limited
F&S Scientific
Cipla
Eldoret oncology
Mercury Healthcare solutions

Apollo Hospitals
LABIOFAM
MSN
HETERO Mylan
Intas Pharmaceuticals Ltd

The 5th International Cancer Conference in 2018 by KESHO hosted in partnership with the Ministry of Health, Kenya, brought together more than 200 participants that comprised both delegates and partners and a myriad of players in cancer management and treatment including health authorities and experts from the state, non-governmental organizations and projects working in screening and surveillance of risk and crisis management as well as scientists, advocacy groups and individuals/persons living with cancer to discuss integrating cancer treatment practice and research. This year over 90 of the participants were doctors with the rest being diverse practitioners mitigating cancer related complexes. The program included diverse content from renowned experts in several related fields, key note speakers from around the world and local clinical specialists and practitioners in research, policy makers and cancer advocates to infuse a more holistic perspective. The attendance for the 5th International Cancer Conference in 2018 by KESHO was as follows: The programme for the 5th Kenya International Cancer Conference 2018.

Loading Viewer...

The programme for the 5th Kenya International Cancer Conference 2018.

Loading Viewer...

Loading Viewer...

View photos of the 2018 conference here

The 4th Kenya International Cancer Conference
2016-11-24 00:00 - 2016-11-26 23:59 | Acacia Premier, Kisumu, Kenya., Kenya
Theme: Taking Cancer Care to the Community

In partnership with Maseno university, KESHO hosted its 4th International Cancer Conference this time in Kisumu, Kenya. The 2016 Conference brought together oncologists and other healthcare professionals involved in or with an interest in cancer, cancer advocacy groups, healthcare policy and financing agencies to present on the following topics:
Cancer prevention, screening, early detection

The fight against cancer – Screening, prevention and treatment.
Environmental protection in cancer prevention.
Diet, lifestyle and cancer

Cancer Epidemiology and Diagnostics

Burkitt’s lymphoma and the Eastern African ecosystem.
Cancer epidemiology in East Africa – the Lake Victoria plateau and the Indian Ocean coastal lowlands.
Management of HIV/AIDS-related cancers
Role of PET/CT in cancer management.
How can we leap frog technology for cancer diagnosis in sub-Saharan Africa?

Palliative Care

Establishment of palliative care centres in Eastern Africa – Challenges and Successes.
How to strengthen multidisciplinary cancer care in sub-Saharan Africa.
Establishing networks for cancer care and research in sub-Saharan Africa
The role of spirituality in cancer care: The pros and cons.
Communicating/breaking bad news/telling the diagnosis.

Cancer Control Planning

Establishment of comprehensive cancer care including high dose chemotherapy in sub-Saharan Africa – the hurdles and prospects.
Challenges in increasing radiotherapy facilities in sub-Saharan Africa.
Establishment of County cancer care.
Capacity building for cancer care in Eastern Africa.
Where is sub-Saharan Africa in in the era of personalized cancer therapy?
Access to cancer care in sub-Saharan Africa: The challenges and bottlenecks; the prospects.
Role of Ministries of Health in Africa in Cancer Care.
Challenges of alternative Cancer care; to integrate or not to integrate with conventional care?
Exponential Growth of the Medical Tourism Industry: Curse or Blessing?

The conference saw in attendance over 200 participants from 8 different countries around the world. Twenty four exhibitors participated in this conference.

Takeda
Cancer Alliance
TCC
BBMRI-ERIC
Ampath Oncology
GE
Lancet
Nairobi Hospital

Acino Switzerland
Uwezo
Belaire
Alexandria
Eli Lilly
Henzo
Medserv
Novartis

Salama Pharmacy
Max Foundation
Generics Africa
Janssen Kenya
Sunpar Pharma
Apollo Hospital
Becton Dickinson
KNH

A total of 187 registered for the conference, 158 attended. Twelve (12) international delegates attended the conference. See % attendance in the below chart. Find below the programme for the 4th Kenya International Cancer Conference 2016.

Loading Viewer...

Find below the report for the 4th Kenya International Cancer Conference 2016.

Loading Viewer...

Loading Viewer...

View 2014 conference photos

The 3rd Kenya International Cancer Conference
2014-11-27 00:00 - 2014-11-29 23:59 | Sarova Panafric Hotel, Nairobi, Kenya., Kenya
Theme: Let Us Talk About Cancer.

The Kenya Society of Haematology and Oncology (KESHO) organized its third annual conference from 27 to 30 November 2014 in Nairobi with the theme: Let us talk about cancer. The conference brought together specialists who contribute to the treatment and management of cancer cases. These included haematologists, nurses, oncologists, pathologists, psychological counsellors, radiotherapists and surgeons. The importance of a multidisciplinary approach to cancer management and treatment was emphasized.
In addition, the need to reduce the cost of treatment and address the mass exodus of patients seeking treatment abroad was also raised. Capacity building was also highlighted; this would be done in tandem with acquisition of more diagnostic and treatment facilities in public hospitals in the country. Government was urged to provide incentives for private sector players to invest in the devolved government framework especially in this field. The role of cancer registries was highlighted in helping map the incidences of various cancers in the country. Sickle cell disease and the establishment of a registry was also discussed.
Cancer is among the non-communicable diseases (NCDs) that are increasingly becoming prevalent in Kenya. This could be attributed to changing lifestyles and other factors. The cost of treating the disease is beyond reach for many patients and their families. Cost influences clinical decisions on investigations and treatment issues, posing a challenge to clinicians even when the expertise and equipment to provide the best quality care is available in the country, mainly in private institutions. It was clear that both government and private sector have a role to play in addressing the challenges in cancer management; this can be done through public-private partnerships. The experience of setting up a cancer centre as shared by Texas Cancer Center would guide other players in the establishment of similar facilities.
It was clear that cancer management cannot only be handled by clinicians, the patients, relatives and concerned members of the public have a role to play in creating awareness especially on screening and early detection. Advocacy at both local and international levels is also necessary to ensure that resources are made available for addressing the disease.
Challenges faced by clinicians in handling cancers of the breast, colon and prostate together with sickle cell disease were discussed in detail. The interactive discussion sessions provided participants an opportunity to address issues raised in presentations. The 3rd Kenya International Cancer Conference attracted 13 exhibitors including sponsors:

Astra Zeneca
Texas Cancer Centre
Novartis
Roche
Pema Scientifics

Galaxy
Crown
Lancet
Acino Switzerland
Henzo

MacNaughton
MSD
Kenyatta National Hospital

The conference brought together 187 specialists who contribute to the treatment and management of cancer cases. These included haematologists, nurses, oncologists, pathologists, psychological counsellors, radiotherapists and surgeons. Challenges faced by clinicians in handling cancers of the breast, colon and prostate together with sickle cell disease were discussed in detail. We attracted over 67 doctors from Kenya and the region and 11 delegates from outside Africa. The % attendance for the 3rd Kenya International Cancer Conference was as follows: Find below the programme for the 3rd Kenya International Cancer Conference.

Loading Viewer...

Find below the report for the 3rd Kenya International Cancer Conference 2014.

Loading Viewer...

Loading Viewer...

View 2014 conference photos
